Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myasthenia Gravis × Bortezomib × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 25 Immunoglobulin Light-chain Amyloidosis 5 Paraproteinemias 2 Neoplasms, Plasma Cell 2 beta-Thalassemia 1 Waldenstrom Macroglobulinemia 1 Thalassemia 1 Renal Insufficiency 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Lymphadenopathy 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 HIV Infections 1 Anemia, Sickle Cell 1 Amyloidosis 1

Interventions

rozanolixizumab 5 zilucoplan 3 ravulizumab 3 telitacicept 2 inebilizumab 2 fludarabine 2 Prednisone 2 Cyclophosphamide 2 thymoglobulin 1 remibrutinib 1 prednylidene 1 iptacopan 1 efgartigimod alfa 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 Prednisolone 1 Peripheral Blood Stem Cell Transplantation 1 Melphalan 1 Etoposide 1 Cytarabine 1 Cladribine 1 Carmustine 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡